Call our 24 hours, seven days a week helpline at 800.272.3900
Let us connect you to professionals and support options near you. Please select an option below:
Use Current LocationUse Map Selector
Baseball shortstop, coach and manager Bud Harrelson shared his Alzheimer’s diagnosis in 2018. Following his diagnosis, he was a devoted advocate for the cause.
The Alzheimer’s Association and Gdavis Productions team up to shed light on the importance of early detection of Alzheimer’s and reducing health disparities.
The Alzheimer’s Association & NACCHO select 10 local public health departments selected as the third cohort of Healthy Brain Initiative Road Map Strategists.
Despite Biogen's decision about discontinuing Aduhelm (aducanumab), the Alzheimer’s Association is optimistic about the future of Alzheimer’s treatments.
Black History Month event brings together leaders to discuss strategies for engaging Black Americans in Alzheimer’s and dementia research and clinical trials.
Legislation will reauthorize the BOLD Act & empower public health departments to improve brain health & support dementia caregivers in their communities.
This grant will support respite service providers across the country to ensure services are dementia-capable and provide person-centered care.
This bipartisan legislation will strengthen the dementia public health infrastructure in communities throughout the nation by reauthorizing the BOLD Act.
A passionate presence of purple Alzheimer’s Association and AIM advocates attended the hearing to show their support for these bipartisan Alzheimer’s policies.
The Alzheimer’s Association & the Society for American Baseball Research will provide dementia information & resources through baseball-centric sessions.
The Alzheimer's Association appreciates the Food and Drug Administration's (FDA) thorough process in reviewing treatments for Alzheimer's disease.
The four bipartisan bills, including the BOLD and NAPA reauthorizations, mark progress in the fight against Alzheimer’s and all other dementia.
The AADAPT Act will empower primary care providers to better diagnose Alzheimer’s and deliver high-quality, person-centered care in community-based settings.
Four bipartisan bills will grow momentum in the fight against Alzheimer’s and all other dementia by reauthorizing critical laws set to expire soon.
The 2024 Facts & Figures report also shows the latest national & state-by-state statistics on Alzheimer’s disease prevalence, mortality, costs & more.
Bipartisan congressional leaders have announced a $100 million increase for Alzheimer’s and dementia research funding, plus $34 million for the BOLD Act.
Leading tau experts from academia, industry and government will meet in Washington, D.C., and online to discuss this essential aspect of dementia research.
The second annual competition focused on increasing access to quality, person-centered care for people living with Alzheimer's in underserved communities.
These projects showcase innovative strategies for enhancing research capacity and promise to advance dementia research.
Conference participants in San Diego and online will explore opportunities to improve dementia research and practice in Hispanic and Latino populations.
Today, the Alzheimer’s Association and Rippl announced a partnership designed to revolutionize access to high-quality dementia care across the country.
This financial commitment will support a new amyloid removal trial launched by DIAN-TU, one of the world's leading Alzheimer's prevention studies.
Vern Buchanan, Nanette Barragán and Elizabeth Fowler received the AIM Humanitarian Award for their contributions to the Alzheimer’s and dementia community.
The Anne and Henry Zarrow Foundation made its second $5 million grant to the Alzheimer’s Association to support the Zenith Fellows Awards research program.
Three clinical trials investigating promising therapies for Alzheimer's and other dementias are being propelled forward by the new funding from Part the Cloud.
The Part the Cloud Gala is part of a global movement started by Michaela "Mikey" Hoag to accelerate scientific progress in Alzheimer's disease research.
AAIC Neuroscience Next showcases research from the next generation of Alzheimer’s and dementia scientists and clinicians.
The AADAPT Act will empower primary care providers to better understand and diagnose dementia and emphasize person-centered care in community-based settings.
Leading dementia scientists, clinicians and health professionals from around the world will gather in Cape Town and online for the AAIC Satellite Symposium.
The new Superhub will focus on recruiting, training and supporting health systems and other providers to build dementia care expertise in all communities.
The Senate Committee on Health, Education, Labor and Pensions (HELP) passed the bipartisan BOLD Infrastructure for Alzheimer’s Reauthorization Act.
During Alzheimer's & Brain Awareness Month in June, the Alzheimer’s Association offers 5 suggestions to take charge of your brain health and join the cause.
The partnership will address health inequities and support individuals and families affected by Alzheimer's and dementia in the African American community.
If approval is granted by the FDA, donanemab will be the second traditional approval of an Alzheimer’s treatment to change the underlying course of the disease.
The partnership aims to reach LGBTQ+ individuals and families with dementia information and support resources.
The new study will focus on how improving care interactions between staff and people living with dementia may improve health outcomes and satisfaction.
The criteria reflect recent advancements in Alzheimer's research, diagnostics and treatment with updated biomarker classification and revised disease staging.
The paper from the Alzheimer's Association and Bank of America encourages employers to foster dementia-friendly workplaces as cognitive impairment rates rise.
The Alzheimer’s Association celebrates today’s FDA approval of Kisunla™ (donanemab) for the treatment of people living with early symptomatic Alzheimer’s.
This year's 21 recipients are the first in a five-year, $25 million grant program to enhance respite services for dementia caregivers nationwide.
The Alzheimer’s Association is disappointed by the European Medicines Agency decision to recommend against allowing Leqembi to be marketed in the EU.
The first issue of Alzheimer’s & Dementia®: Behavior & Socioeconomics of Aging (A&D: BSEA) will debut in fall 2024.
New research suggests that blood tests for Alzheimer's may revolutionize accuracy of diagnosis, support research participation and speed access to treatment.
The Alzheimer’s Association recognizes six researchers for their varied expertise, noteworthy achievements & innovative contributions to dementia science.
“Their visionary leadership and unwavering dedication reflect Jerome H. Stone’s commitment to advancing Alzheimer’s research and supporting all those affected.”
Exposure to wildfire smoke increases the risk of dementia more than other types of air pollution, according to a decade-long study in southern California.
A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial results reported at AAIC.
Today, the Senate unanimously passed bipartisan legislation that will renew the nation’s commitment to addressing Alzheimer’s and all other dementia.
New research from AAIC shows that people who eat at least two servings a week of bacon, bologna or other processed red meat have a higher risk of dementia.
New research results reported at AAIC 2024 are advancing what we know about risk, diagnosis and treatment of Alzheimer’s disease and other dementias.
While the U.K. approval of Leqembi (lecanemab) is an important milestone, denying access through the National Health Service will deepen global health inequity.
“Falling Together” will premiere on Hallmark Channel at 8 p.m. ET / 7 p.m. CT on Sept. 21, which is also World Alzheimer’s Day.
Edward Jones will serve as national presenting sponsor with Biogen and Eisai as national sponsors for the 2024 Alzheimer's Association Walk to End Alzheimer’s.
The NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act will now head to the White House to be signed into law.
The partnership will elevate awareness of Alzheimer’s disease and other dementias and offer care and support resources to individuals, families and communities.
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act will build on the progress made in the fight against Alzheimer’s.
Eisai Inc. will evaluate clinical safety outcomes among early Alzheimer’s patients and collaborate on an ALZ-NET-affiliated study.
The Clinical Meaningfulness Workgroup developed recommendations to help health care providers explain new Alzheimer’s treatments to patients and caregivers.
The essentiALZ program now offers Spanish-language dementia care education for professional care providers in long-term and community-based care settings.
The Alzheimer’s Association is disappointed that the U.K. has decided to block NHS coverage of Kisunla® (donanemab), a disease modifying Alzheimer’s treatment.
The event, founded by Princess Yasmin Aga Khan, was hosted by Wayne Brady and featured a performance by Leslie Odom Jr.
The event, founded by Kimberly Williams-Paisley, raised $250,000 and counting for the Alzheimer's Association research grant program.
Find caregiving support and information during National Family Caregivers and National Alzheimer’s Disease Awareness Month this November.
The summit will convene state agency officials tasked with developing, advancing and implementing dementia-specific policies across state agencies.
The Alzheimer’s Association welcomes the European Medicines Agency's decision to recommend the approval of Leqembi® (lecanemab) for marketing in Europe.
In the Alzheimer's Association journal, authors discuss Public and Participant Involvement (PPI) and working with community members in dementia studies.
Find gift ideas for individuals living in the early, middle and late stages of Alzheimer's disease, as well as gifts for dementia caregivers.
The BOLD Infrastructure for Alzheimer's Reauthorization Act will empower public health departments to implement dementia interventions in their communities.
Stars share how Alzheimer’s has impacted those they love to encourage people to support the Alzheimer's Association this giving season.
Donate Now
Take the Brain Tour
Learn More